Defibrillator reliability: Guidant, Medtronic and St Jude on the spot
This article was originally published in Clinica
The three main manufacturers of implantable cardiac defibrillators (ICDs) have all been dragged into the headlines this week, and not for the best of reasons. After a run of damaging announcements, analysts concluded that the take-home message is that we must not forget that no implantable, electronic device is failsafe, and that no manufacturer's business is immune from damage when something goes wrong.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.